5AM Partners IV, LLC - 06 Oct 2022 Form 4 Insider Report for scPharmaceuticals Inc. (SCPH)

Role
10%+ Owner
Signature
5AM Partners IV, LLC, By /s/ Scott M. Rocklage, Managing Member
Issuer symbol
SCPH
Transactions as of
06 Oct 2022
Net transactions value
-$2,488,907
Form type
4
Filing time
11 Oct 2022, 19:10:31 UTC
Previous filing
16 Sep 2022
Next filing
02 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SCPH Common Stock Sale $152,894 -30,457 -1.1% $5.02 2,688,014 06 Oct 2022 By 5AM Ventures IV, L.P. F1
transaction SCPH Common Stock Sale $6,370 -1,269 -1.1% $5.02 112,000 06 Oct 2022 By 5AM Co-Investors IV, L.P. F2
transaction SCPH Common Stock Sale $29,156 -5,808 -1.2% $5.02 497,304 06 Oct 2022 By 5AM Opportunities I, L.P. F3
transaction SCPH Common Stock Sale $1,866,729 -456,413 -17% $4.09 2,231,601 10 Oct 2022 By 5AM Ventures IV, L.P. F1
transaction SCPH Common Stock Sale $77,780 -19,017 -17% $4.09 92,983 10 Oct 2022 By 5AM Co-Investors IV, L.P. F2
transaction SCPH Common Stock Sale $355,977 -87,036 -18% $4.09 410,268 10 Oct 2022 By 5AM Opportunities I, L.P. F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

5AM Partners IV, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The shares are directly held by 5AM Ventures IV, L.P. ("Ventures IV"). 5AM Partners IV, LLC ("Partners IV") is the sole general partner of Ventures IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures IV. Each of Partners IV, Dr. Diekman, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of such shares except to the extent of its or his pecuniary interest therein.
F2 The shares are directly held by 5AM Co-Investors IV, L.P. ("Co-Investors IV"). Partners IV is the sole general partner of Co-Investors IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Co-Investors IV. Each of Partners IV, Dr. Diekman, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of such shares except to the extent of its or his pecuniary interest therein.
F3 Shares are directly held by 5AM Opportunities I, L.P. ("Opportunities"). 5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Andrew J. Schwab is a managing member of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP and Mr. Schwab disclaims beneficial ownership of such shares, except to the extent of its or his pecuniary interest therein.